Giovanni Sorropago
Overview
Explore the profile of Giovanni Sorropago including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cacia M, Cozzi O, Gohar A, Mangieri A, Sorropago G, Pacchioni A, et al.
Cardiovasc Revasc Med
. 2022 Nov;
53S:S144-S148.
PMID: 36402699
No abstract available.
2.
Salvi P, Baldi C, Scalise F, Grillo A, Salvi L, Tan I, et al.
J Am Heart Assoc
. 2021 Sep;
10(17):e021207.
PMID: 34465133
Background Estimation of the balance between subendocardial oxygen supply and demand could be a useful parameter to assess the risk of myocardial ischemia. Evaluation of the subendocardial viability ratio (SEVR,...
3.
Singh G, Scalise F, Bianchi P, Cireni L, Sorropago G, Casana R, et al.
Ann Vasc Surg
. 2021 Aug;
78:190-196.
PMID: 34464729
Background: A total percutaneous approach for management of aortic pathologies with endovascular grafts requires the use of large size delivery-systems. The diameter of these delivery systems usually exceeds the recommended...
4.
Scalise F, Margonato D, Sole A, Sorropago A, Sorropago G, Mancia G
Blood Press
. 2020 Jul;
29(6):375-381.
PMID: 32608283
Purpose: Cuffless blood pressure (CL-BP) measurements are believed to be a potentially alternative to cuff-occlusion-based (C-BP) measurement. A new cuffless device was developed for ambulatory BP monitoring. We assessed the...
5.
Scalise F, Sole A, Singh G, Sorropago A, Sorropago G, Ballabeni C, et al.
J Hypertens
. 2020 Jan;
38(5):936-942.
PMID: 31990900
Introduction: Recent randomized controlled trials have confirmed the ability of renal denervation to lower blood pressure (BP) in patients, resistant to the BP-lowering effect of multiple antihypertensive drug administration. Evidence...
6.
Salvi P, Scalise F, Rovina M, Moretti F, Salvi L, Grillo A, et al.
Hypertension
. 2019 May;
74(1):117-129.
PMID: 31132954
Aortic pulse wave velocity is a worldwide accepted index to evaluate aortic stiffness and can be assessed noninvasively by several methods. This study sought to determine if commonly used noninvasive...
7.
Sorropago G, Singh G, Sorropago A, Sole A, Rossi J, Tolva V, et al.
EuroIntervention
. 2018 Oct;
14(12):e1278-e1285.
PMID: 30327287
Aims: The success of transfemoral transcatheter aortic valve implantation (TAVI) and thoraco-abdominal aneurysm repair (TAAR) depends on haemostatic control of the access site, which is usually obtained with suture-based closure...
8.
Grillo A, Parati G, Rovina M, Moretti F, Salvi L, Gao L, et al.
Am J Hypertens
. 2017 Oct;
31(1):80-88.
PMID: 29059329
Background: Aortic pulse wave velocity (PWV) is an indirect index of arterial stiffness and an independent cardiovascular risk factor. Consistency of PWV assessment over time is thus an essential feature...
9.
Sardella G, Stella P, Chiarito M, Leone A, Balian V, Prosperi F, et al.
Catheter Cardiovasc Interv
. 2017 Jul;
91(5):884-891.
PMID: 28707375
Background: Patients with diabetes mellitus (DM) remain at higher risk of restenosis after percutaneous coronary intervention despite the use of contemporary drug-eluting stents. The Cre8 amphilimus-eluting stent (AES) has shown...
10.
Scalise F, Auguadro C, Sorropago G, Sorropago A, Novelli E, Finizio M, et al.
J Interv Cardiol
. 2016 Jun;
29(4):406-13.
PMID: 27338839
Introduction: Percutaneous patent foramen ovale (PFO) closure by means of a septal occluder device (SOD) is a well-known therapeutic strategy for the secondary prevention of paradoxical embolic neurological events. The...